Skip to content

Efficacy of Petshuddhi Churna in patients having Constipation

An open Label, Single arm Clinical Study to Evaluate the efficacy of Petshuddhi Churna in patients having Constipation. - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/07/091855
Enrollment
50
Registered
2025-07-28
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K928- Other specified diseases of the digestive system

Interventions

Intervention1: Test Product: Petshuddhi Churna: Dose: 1Tablespoon at bedtime with lukewarm water Route of Administration: Oral Duration: Day 7 Control Intervention1: Not Applicable: Not Applicable

Sponsors

Jeena Sikho Lifecare Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subject from 18-65 years of age. 2. Subject having problem in passing stool. (Constipation) 3. Subjects that are able to give written informed consent in a manner approved by the institutional ethics committee and comply with the requirements of the study. 4. Subject willing to avoid participation in any other interventional clinical trial for the duration of the study.

Exclusion criteria

Exclusion criteria: 1. Have used, are using, or are planning to use immunosuppressive or immunomodulatory medication (i.e., biologics), including oral or parenteral corticosteroids. 2. Subjects that have participated in any other interventional clinical trial in the previous 90 days. 3. Heart patients will no enrolled. 4. Subjects with known sensitivity to any of the constituents of the investigational product. 5. Any clinically significant systemic or cutaneous disease, which may interfere with study treatment or procedures. 6. Chronic illness which may influence the outcome of the study. 7. Pregnant/nursing mothers

Design outcomes

Primary

MeasureTime frame
1. Complete bowel defaecation Score 2. Bristol Stool score form 3. SGATimepoint: Time Points: Day1 and Day 7

Secondary

MeasureTime frame
1. Change in the CBC 2. Change in the LFTTimepoint: Time Points: Day1 & Day7

Countries

India

Contacts

Public ContactPuneet Mittal

CCFT Laboratories

puneetmittal@mgcts.org08937015757

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026